SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-020137
Filing Date
2021-08-16
Accepted
2021-08-16 16:03:15
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1026142
2 ex31-1.htm EX-31.1 11806
3 ex31-2.htm EX-31.2 11795
4 ex32.htm EX-32 6112
  Complete submission text file 0001493152-21-020137.txt   5118757

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE yewb-20210630.xsd EX-101.SCH 45952
6 XBRL CALCULATION FILE yewb-20210630_cal.xml EX-101.CAL 70321
7 XBRL DEFINITION FILE yewb-20210630_def.xml EX-101.DEF 130973
8 XBRL LABEL FILE yewb-20210630_lab.xml EX-101.LAB 351150
9 XBRL PRESENTATION FILE yewb-20210630_pre.xml EX-101.PRE 252077
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 738704
Mailing Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Business Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731 626-401-9588
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 211177791
SIC: 0100 Agricultural Production-Crops